Speaker illustration

Doctor Al Bellibas

The Medicines Company, Parsippany (United States of America)

Body weight does not affect systemic PK exposure parameters of MDCO-216 in healthy volunteers and CAD patients

Event: ESC CONGRESS 2016

Topic: CAD and comorbidities

Session: Comorbidities and risk for CAD

Thumbnail

ESC 365 is supported by

logo Novo Nordisk